Search results
25 cze 2019 · If a woman has taken methyldopa to treat pre-eclampsia, stop within 2 days after the birth and change to an alternative treatment if necessary (for choice of antihypertensive during the postnatal period, see the section on antihypertensive treatment during the postnatal period, including during breastfeeding).
- Recommendations for Research
Recommendations for Research - Hypertension in pregnancy:...
- Finding More Information and Committee Details
Finding More Information and Committee Details -...
- Update Information
Update information. April 2023: In recommendations 1.3.12...
- Context
Context - Hypertension in pregnancy: diagnosis and...
- Rationale and Impact
Rationale and Impact - Hypertension in pregnancy: diagnosis...
- Evidence Review B: Monitoring Gestational Hypertension
Developing NICE guidelines: the manual 2014. Methods...
- Evidence Review C: Prediction of Complications in Pre-Eclampsia
Evidence Review C: Prediction of Complications in...
- Evidence Review D: Interventions for Pre-Eclampsia
Evidence Review D: Interventions for Pre-Eclampsia -...
- Recommendations for Research
29 wrz 2023 · Consider intravenous remifentanil patient-controlled analgesia (PCA), at 40 micrograms per bolus with a 2‑minute lockout period, as an option for women who want ongoing pain relief during labour and birth. In September 2023, this was an off-label use of remifentanil.
•In the early post-partum period, women with pre-eclampsia should be considered at high risk for pre-eclamptic complications for at least 3 days and should have their clinical condition monitored at least every four hours while awake. •AN antihypertensives should be continued, and consideration
Women who develop severe pre-eclampsia and eclampsia. The guidance encompasses the principles within the NICE clinical guidance (NG133) hypertension in pregnancy: diagnosis and management, and NICE Quality Standard number 35 hypertension in pregnancy.
Guideline . Covers diagnosing and managing hypertension (high blood pressure), including preeclampsia, during pregnancy, labour and birth. Includes advice for women with hypertension who wish to conceive and women who have had a pregnancy complicated by hypertension.
The recommendations on management of women at high risk of, or exhibiting clincical featues of pre-eclampsia are largely based on expert opinion in the National Institute of Health and Care Excellence (NICE) guideline Hypertension in pregnancy: diagnosis and management [NICE, 2019b]. Early referral to obstetrics
Recommendations for research. As part of the 2019 update, the guideline committee made 6 research recommendations on the management of pregnancy with chronic hypertension, pre-eclampsia, fetal monitoring, the use of antihypertensives in breastfeeding and advice and follow-up.
